Guanren Zhao
Overview
Explore the profile of Guanren Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Z, Wang F, Huang X, Chen Z, Zhao Y, Wang Y, et al.
Anal Cell Pathol (Amst)
. 2023 Feb;
2023:6306358.
PMID: 36845756
Phagocytic ability of macrophage is responsible for tuberculosis infection. Nicotine has been shown to attenuate the phagocytic ability of macrophage; however, the underlying mechanism remains unclear. Here, we demonstrated that...
2.
Zhao G, Yang F, Yang Q, Yang Y, Xu A, Chen Y, et al.
Transl Androl Urol
. 2022 Oct;
11(9):1292-1303.
PMID: 36217405
Background: Compound aluminum sulfate injection (CASI) originated from a Chinese traditional medicine, "Kuzhiye", and has been used in treating non-muscle invasive bladder cancer (NMIBC). Previous studies suggested that CASI was...
3.
Zhao G, Chen M, Sun L, Xi N
Ann Transl Med
. 2022 May;
10(8):461.
PMID: 35571444
Background: The four most commonly used first-line anti-tuberculosis (TB) drugs in clinical practice are isoniazid (INH), rifampicin (RFP), ethambutol (EMB), and pyrazinamide (PZA). The plasma concentration of anti-TB drugs is...
4.
Zhao G, Luo X, Han X, Liu Z
Saudi Med J
. 2020 Apr;
41(4):351-360.
PMID: 32291421
Objectives: To identify the novel and promising indicators for pulmonary tuberculosis (PTB) patients. Methods: The study was carried out between June 2016 and June 2019. Three RNA sequencing or microarray...
5.
Che L, Liu Z, Wang D, Xu C, Zhang C, Meng J, et al.
Acta Biomater
. 2019 Jul;
97:461-473.
PMID: 31344512
Nanomedicine with programmed drug release can give full play to the synergistic effect of multi-component system in complicated tumor environment. However, the construction of these programmed drug delivery systems often...
6.
Liu Z, Lu C, Zhao G, Han X, Dong K, Wang C, et al.
J Cell Biochem
. 2019 Jun;
120(10):18370-18377.
PMID: 31190333
Background: Nicotine, an important component of tobacco, is a major risk factor of lung cancer, but the mechanism through which nicotine promotes lung cancer development remains unclear. Methods: Eighty patients...
7.
Wu M, Zhao G, Zhuang X, Zhang T, Zhang C, Zhang W, et al.
Onco Targets Ther
. 2018 Jun;
11:2945-2954.
PMID: 29849464
Background: Triclosan is a widely applied antimicrobial agent which affects the endocrine system and homeostasis; it may also promote the cirrhosis and hepatocellular carcinoma (HCC) growth in a mice model....
8.
Zhao G, Long L, Zhang L, Peng M, Cui T, Wen X, et al.
Sci Rep
. 2017 Jun;
7(1):3383.
PMID: 28611459
A new acidly sensitive PEGylated polyethylenimine linked by Schiff base (PEG-s-PEI) was designed to render pH-sensitive PEGylation nanoassemblies through multiple interactions with indomethacin and docetaxel (DTX). DTX nanoassemblies driven by...
9.
Xue C, Zhou C, Yang B, Lv J, Dai B, Yu S, et al.
BMJ Open
. 2017 Feb;
7(2):e013672.
PMID: 28237959
Introduction: Co-administration of a diuretic or calcium channel blocker with an ACE inhibitor are both preferred combinations in patients with hypertensive chronic kidney disease (CKD). According to the available evidence,...